Eckert & Ziegler Extends Ga-68 Activities in Japan
Eckert & Ziegler (ISIN DE0005659700, SDAX) expands its activities on Gallium-68 (Ga-68) labeled diagnostics in Japan to…
Eckert & Ziegler (ISIN DE0005659700, SDAX) expands its activities on Gallium-68 (Ga-68) labeled diagnostics in Japan to…
Eckert & Ziegler (ISIN DE0005659700, SDAX) weitet gemeinsam mit Novartis Pharma K.K. (Japan) seine Aktivitäten im Bereic…
EvidentIQ Germany, formerly known as XClinical, a top provider of EDC software, is proud to mark a decade of fruitful co…
Eckert & Ziegler (ISIN DE0005659700, TecDAX) announced that the Clinical Trial Notification (CTN) of a joint clinical st…
Eckert & Ziegler (ISIN DE0005659700, TecDAX) hat von der japanischen Arzneimittelbehörde PMDA (Pharmaceuticals and Medic…
The World Association of News Publishers (WAN-IFRA), the International Publishers Association (IPA), and the Internation…
Last week, the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) registered relyon plasma as a foreign manufact…
Die japanische Pharmaceuticals and Medical Devices Agency (PMDA) hat relyon plasma in der vergangenen Woche als „Foreign…
. MAGELLAN-AMD-Studie untersucht vergleichbare Wirksamkeit, Sicherheit und Immunogenität von Formycons Aflibercept-Bio…
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the Japanese Pharmaceuticals and Medical De…